Jill Lacy, MD

Professor of Medicine (Medical Oncology)

Clinical Interests

  • Hodgkin Disease
  • Lymphoma
  • Medical Oncology

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Brain Tumor Center | Gastrointestinal Cancer Program | Sarcoma Oncology Program

Medical Oncology: Subset Medical Oncology Faculty

Yale Medical Group

Board Certifications

  • Medical Oncology AB of Internal Medicine (1991)

Clinical Trials

Conditions Study Title
Pancreas Phase II Study of Peri-Operative Modified Folfirinox in Localized Pancreatic Cancer
Pancreas A phase 3, multicenter, open-label, randomized study of nab-Paclitaxel plus gemcitabine versus gemcitabine alone as adjuvant therapy in subjects with surgically resected pancreatic adenocarcinoma
Pancreas nab-paclitaxel (Abraxane) plus Gemcitabine in subjects with locally Advanced pancreatic cancer (LAPC): an International, open-label, multi-center, Phase 2 study (LAPACT)
Other Digestive Organ, Stomach A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Capecitabine and Cisplatin With or Without Ramucirumab as First-line Therapy in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (RAINFALL)
Pancreas Multicenter Randomized Phase II Study of NPC-1C in Combination with Gemcitabine and nab-Paclitaxel versus Gemcitabine and nab-Paclitaxel alone in Patients with Metastatic or Locally Advanced Pancreatic Cancer Previously Treated with FOLFIRINOX

Edit this profile

Contact Info

Jill Lacy, MD
Patient Care Location
Smilow Cancer Hospital at Yale-New HavenYale-New Haven Hospital
20 York Street, Ste North Pavilion 8

New Haven, CT 06510
Mailing Address
PO Box 208028
New Haven, CT 06520-8028